Alembic receives USFDA final approval for Alcaftadine Ophthalmic Solution, 0.25% (OTC)
Alcaftadine Ophthalmic Solution, 0.25% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
Alcaftadine Ophthalmic Solution, 0.25% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
Potential of Ayurveda’s contribution in global health system through various innovative practices
India has taken the lead in recognising NAFLD as a major non-communicable disease
The company will also share results in two additional posters for deuruxolitinib
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Quinidine Sulphate helps manage rare irregular heartbeat conditions
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Subscribe To Our Newsletter & Stay Updated